Pharma channel feed

No­var­tis, Sanofi and PhRMA push FDA on how to bet­ter han­dle com­plex tri­al de­signs

Last year
FDA+

No­var­tis to re­duce de­vel­op­ment team by near­ly 700 po­si­tions

Last year
People

Vir­ginia gov­er­nor ve­toes bill to cre­ate ad­vi­so­ry board to re­duce drug prices

Last year
FDA+

In­di­an phar­ma re­ceives FDA warn­ing let­ter for bare­foot em­ploy­ees and gen­er­al 'dis­re­pair'

Last year
FDA+
Manufacturing

Mon­sters, di­nosaurs and su­per­heroes: Why phar­ma is bring­ing char­ac­ters back in­to the ad mix 

Last year
Marketing

Mar­ket­ingRx roundup: Study finds gener­ic drugs gain ground, but docs still pre­fer brands; Pfiz­er laud­ed at AACR

Last year
Marketing

FDA of­fi­cials raise con­cerns with im­munother­a­py overuse for ear­ly-stage can­cer pa­tients: #AACR24

Last year
FDA+

Over a year af­ter biosim­i­lars start­ed com­pet­ing, Ab­b­Vie still holds 96% of Hu­mi­ra mar­ket, re­port says

Last year

Near­ly half of can­cer drugs grant­ed ac­cel­er­at­ed ap­proval didn’t end up show­ing clin­i­cal ben­e­fit — study

Last year
FDA+

SEC notch­es win in bio­phar­ma 'shad­ow' in­sid­er trad­ing case

Last year

Take­da ex­tends rare dis­ease aware­ness cam­paign with pa­tient-in­spired im­agery, sto­ries

Last year
Marketing

FDA ap­proves J&J and Leg­end’s Carvyk­ti for sec­ond-line mul­ti­ple myelo­ma

Last year
Cell/Gene Tx
FDA+

FDA grants En­her­tu tu­mor-ag­nos­tic ac­cel­er­at­ed ap­proval

Last year
FDA+

Sanofi to cut jobs in pipeline re­struc­tur­ing

Last year
People

Loos­en­ing Med­ic­aid re­stric­tions on hep C drugs could im­prove pa­tient ac­cess, study finds

Last year
FDA+

Bris­tol My­ers and 2sev­en­ty win la­bel ex­pan­sion for Abec­ma in ear­li­er mul­ti­ple myelo­ma

Last year
FDA+

LENZ ral­lies pres­by­opia aware­ness with eye­care pro­fes­sion­als ahead of FDA sub­mis­sion

Last year
Marketing

As­traZeneca un­veils pos­i­tive Phase 3 da­ta to move Imfinzi in­to ear­li­er stages of lung can­cer

Last year
R&D

J&J buys an­oth­er medtech com­pa­ny in $13.1B Shock­wave deal

Last year
Deals

US-Chi­na ten­sions threat­en to en­snare ad­di­tion­al Chi­nese bio­phar­ma con­trac­tors

Last year
China
Manufacturing

Am­gen taps Tik­Tok trends, orig­i­nal con­tent and ‘su­per fan’ em­ploy­ees in its so­cial me­dia strat­e­gy

Last year
Marketing

Paxlovid didn’t short­en Covid symp­toms in vac­ci­nat­ed adults, full tri­al re­sults con­firm

Last year
FDA+
Coronavirus

Judge of­fers ear­ly win for Ar­bu­tus as Mod­er­na vac­cine patent spat heats up

Last year
Law

Sanofi ends al­most all state per­son­al in­jury law­suits over Zan­tac with undis­closed set­tle­ment

Last year
Law
First page Previous page 60616263646566 Next page Last page
A service from the Financial Times